Search Results
Results found for "assay development"
- Mechanistic Understanding of the Palmitoylation of Go Protein in the Allosteric Regulation of...
G-protein-coupled receptors (aGPCRs)-a major family of GPCRs-play critical roles in the regulation of tissue development
- Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone...
regarding the complex biology of the preproglucagon-derived hormones, their signaling, and the drug development
- Structural basis for receptor selectivity and inverse agonism in S1P5 receptors
Several S1PR therapeutic drugs have been developed to treat these diseases; however, they lack receptor
- The Bile Acid Membrane Receptor TGR5 in Cancer: Friend or Foe?
regulating proliferation, inflammation, adhesion, migration, insulin release, muscle relaxation, and cancer development
- California gold rush for Sosei Heptares
The vision is to develop novel muscarinic receptor agonists for schizophrenia and other neuropsychiatric
- Reflections on My PhD Journey: Lessons Learned
It challenges you to push your limits, adapt to unforeseen challenges, and develop habits that will serve
- Although the cannabinoid type-2 receptor (CB2) is highly expressed in the immune system, emerging...
The development of new CB2-related pharmacological and genetic tools, including the first small molecule
- Addex Raises $10 Million In Equity Financing
, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development
- 📰 GPCR Weekly News, January 29 to February 4, 2024
ectodomain GPCR Activation and Signaling GPCR signaling bias: an emerging framework for opioid drug development organization at the plasma membrane Industry News Launch of GIO Therapeutics, founded by Cumulus Oncology, to develop
- Therapeutic validation of an orphan G protein‐coupled receptor
shown to play key roles in various physiological functions, such as sensory perception, reproduction, development From these series of compounds, GLPG1205 progressed into clinical development for the potential treatment
- To probe the activation mechanism of the Delta opioid receptor by an agonist ADL5859 started from...
These insights will facilitate further development of therapeutic agents targeting the DOR.Communicated
- Lysine 101 in the CRAC Motif in Transmembrane Helix 2 Confers Cholesterol-Induced Thermal...
in structural biological advancements of GPCRs and design of thermally stabilized receptors for drug development
- Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR
library for its industry-leading biology platform to identify potential GPCR targets and advance the development
- Bell-Evans model and steered molecular dynamics in uncovering the dissociation kinetics of ligands..
receptors "Recently, academic and industrial scientific communities involved in kinetics-based drug development
- Gαs and Gαq/11 protein coupling bias of two AVPR2 mutants (R68W and V162A) that cause nephrogenic di
conformation of the receptor and consequently activated signaling pathways, and also may shed light on the development
- Addex raises $4.2 million in equity financing
, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development
- Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage ...
translational medicine capabilities • ‘Venture-like’ capital allocation approach to focus pipeline development
- Effect Delta-9-tetrahydrocannabinol and cannabidiol on milk proteins and lipid levels in HC11 cells
impact of cannabis or its components, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), on MG development
- Intermolecular Interactions in G Protein-Coupled Receptor Allosteric Sites at the Membrane Interface
Calculations "Allosteric modulators are called promising candidates in G protein-coupled receptor (GPCR) drug development
- GRK2 in cardiovascular disease and its potential as a therapeutic target
Thus, identifying novel molecular targets for developing HF therapeutics remains a key research focus
- Newly launched antibody libraries put hard-to-drug targets within reach
Antibody developers are increasingly utilising antibody libraries to derive high-quality, drug-like biologics
- TeachOpenCADD - A teaching platform for computer-aided drug design
TeachOpenCADD is a teaching platform developed by students for students, which provides teaching material
- Precise druggability of the PTH type 1 receptor
peptide-binding pocket embedded deep within the transmembrane domain limits the identification and development
- Increased Anxiety-like Behaviors in Adgra1-/- Male But Not Female Mice are Attributable to...
amygdalae of male mice, implicating a potential, therapeutic application in novel anti-anxiety drug development
- Enhanced membrane binding of oncogenic G protein αqQ209L confers resistance to inhibitor YM-254890
if this loss of PM localization could contribute to the mechanism of inhibition of αqQ209L by YM, we developed
- PH-Binding Motif in PAR4 Oncogene: From Molecular Mechanism to Drug Design
attenuates PAR2&4-Akt/PKB associations; PAR4 instigated Matrigel invasion and migration in vitro and tumor development
- GPR125 (ADGRA3) is an autocleavable adhesion GPCR that traffics with Dlg1 to the basolateral...
These receptors are expressed widely and involved in various functions including development, angiogenesis
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
If you work on GPCRs across translational pharmacology, drug development, or molecular pharmacology,
- Trevena Announce Submission of New Drug Application in China for OLINVYK® by its Partner Jiangsu ...
royalty on net sales in China CHESTERBROOK, Pa., Jan. 27, 2022 A biopharmaceutical company focused on the development
- New role of β-arrestins in MOR signaling
severe acute or chronic pain conditions, but their use is overshadowed by their side effects and by the development Morphine is an agonist of Mu opioid receptor (MOPR) and one of the objectives in the development of new